Effects of fenamate on inhibitory postsynaptic currents in Purkinje's cells

A Yu Dvorzhak1

  • 1Department of Brain Studies, Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia. a_dvorzhak@mail.ru

Insights

Nonsteroidal anti-inflammatory drugs mefenamic and tolfenamic acids prolong inhibitory currents in mouse brain cells. These fenamate drugs also reduce the amplitude of these crucial neuronal signals.

Area of Science:

  • Neuropharmacology
  • Cellular Neuroscience
  • Drug Discovery

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
  • The fenamate group of NSAIDs, including mefenamic and tolfenamic acids, are known for their analgesic properties.
  • Understanding the precise cellular mechanisms of NSAIDs, particularly their effects on neuronal signaling, is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effects of mefenamic acid and tolfenamic acid on spontaneous miniature inhibitory postsynaptic currents (mIPSCs) in Purkinje cells.
  • To determine how these fenamate NSAIDs modulate the amplitude and duration of inhibitory neurotransmission in the cerebellum.

Main Methods:

  • Whole-cell patch-clamp recordings were performed on Purkinje cells in mouse cerebellar slices.
  • The study utilized concentrations of mefenamic and tolfenamic acids ranging from 3 to 30 microM.
  • Analysis focused on spontaneous miniature inhibitory postsynaptic currents (mIPSCs) to assess changes in neuronal excitability.

Main Results:

  • Both mefenamic acid and tolfenamic acid significantly prolonged the duration of miniature inhibitory postsynaptic currents.
  • A notable reduction in the amplitude of miniature inhibitory postsynaptic currents was observed with both drugs.
  • These effects were concentration-dependent within the tested range of 3-30 microM.

Conclusions:

  • Fenamate NSAIDs, specifically mefenamic and tolfenamic acids, directly impact inhibitory neurotransmission in Purkinje cells.
  • The observed prolongation and amplitude reduction of mIPSCs suggest a modulatory role of these drugs on GABAergic signaling.
  • These findings contribute to understanding the neuropharmacological actions of fenamate NSAIDs and their potential central nervous system effects.

Related Concept Videos

Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Integration of Synaptic Events01:28

Integration of Synaptic Events

Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...